So, these IgG4 antibodies target some specific nodal and/or paranodal proteins (NF155, NF140/186, CNTN1, or Caspr‐1) and are associated with particular clinical phenotypes of CIDP presenting pathological features of dismantling of paranodal junctions [35]. Here, CNTNAP1 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.